Optical coherence tomography longitudinal evaluation of retinal nerve fiber layer thickness in glaucoma

Archives of Ophthalmology

Volumn 123, Issue 4, 2005, Pages 464-470

  Wollstein, Gadi ^a,b   Schuman, Joel S ^a,b,e   Price, Lori L ^a   Aydin, Ali ^a   Stark, Paul C ^a   Hertzmark, Ellen ^c   Lai, Edward ^a   Ishikawa, Hiroshi ^a,b   Mattox, Cynthia ^a   Fujimoto, James G ^d   Paunescu, Lelia A ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLAUCOMA; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MALE; NERVE FIBER; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; RETINA NERVE CELL; RETROSPECTIVE STUDY; THICKNESS; VISUAL FIELD; COMPARATIVE STUDY; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; METHODOLOGY; MIDDLE AGED; OPTIC NERVE DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RETINA GANGLION CELL; VISUAL SYSTEM EXAMINATION;

AGED; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; NERVE FIBERS; OCULAR HYPERTENSION; OPTIC NERVE DISEASES; PERIMETRY; RETINAL GANGLION CELLS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL FIELDS;

EID: 20144389022     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.4.464     Document Type: Article

References (56)

1. Sommer A, Pollack I, Maumenee A. Optic disc parameters and onset of glaucomatous field loss, I: methods and progressive changes in disc morphology. Arch Ophthalmol. 1979;97:1444-1448.
2. Pederson J, Anderson D. The mode of progressive disc cupping in ocular hypertension and glaucoma. Arch Ophthalmol. 1980;98:490-495.
3. Sommer A, Quigley H, Robin A. Evaluation of nerve fiber layer assessment. Arch Ophthalmol. 1984;102:1766-1771.
4. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol. 1991;109:77-83.
5. Quigley HA, Katz J, Derick RJ, et al. An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology. 1992;99:19-28.
6. Zeyen TG, Caprioli J. Progression of disc and field damage in early glaucoma. Arch Ophthalmol. 1993;111:62-65.
7. Quigley HA, Enger C, Katz J, et al. Risk factors for the development of glaucomatous visual field loss in ocular hypertension. Arch Ophthalmol. 1994;112:644-649.
8. Sommer A, Miller NR, Pollack I, Maumenee AE, George T. The nerve fiber layer in the diagnosis of glaucoma. Arch Ophthalmol. 1977;95:2149-2156.
9. Chauhan BC, McCormick TA, Nicolela MT, LeBlanc RP. Optic disc and visual field changes in a prospective longitudinal study of patients with glaucoma: comparison of scanning laser tomography with conventional perimetry and optic disc photography. Arch Ophthalmol. 2001;119:1492-1499.
10. Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713; discussion 829-830.
11. Schuman JS, Hee MR, Puliafito CA, et al. Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. Arch Ophthalmol. 1995;113:586-596.
12. Mikelberg FS, Parfitt CM, Swindale NV. Ability of the Heidelberg Retina Tomograph to detect early glaucomatous visual field loss. J Glaucoma. 1995;4:242-247.
13. Weinreb RN, Zangwill L, Berry CC, et al. Detection of glaucoma with scanning laser polarimetry. Arch Ophthalmol. 1998;116:1583-1589.
14. Wollstein G, Garway-Heath DF, Hitchings RA. Identification of early glaucoma cases with the scanning laser ophthalmoscope. Ophthalmology. 1998;105:1557-1563.
15. Zeimer R, Asrani S, Zou S, et al. Quantitative detection of glaucomatous damage at the posterior pole by retinal thickness mapping: a pilot study. Ophthalmology. 1998;105:224-231.
16. Wollstein G, Garway-Heath DF, Fontana L, Hitchings RA. Identifying early glaucomatous changes: comparison between expert clinical assessment of optic disc photographs and confocal scanning ophthalmoscopy. Ophthalmology. 2000;107:2272-2277.
17. Yamada N, Chen PP, Mills RP, et al. Glaucoma screening using the scanning laser polarimeter. J Glaucoma. 2000;9:254-261.
18. Bowd C, Zangwill LM, Berry CC, et al. Detecting early glaucoma by assessment of retinal nerve fiber layer thickness and visual function. Invest Ophthalmol Vis Sci. 2001;42:1993-2003.
19. Choplin NT, Lundy DC. The sensitivity and specificity of scanning laser polarimetry in the detection of glaucoma in a clinical setting. Ophthalmology. 2001;108:899-904.
20. Miglior S, Casula M, Guareschi M, et al. Clinical ability of Heidelberg retinal tomograph examination to detect glaucomatous visual field changes. Ophthalmology. 2001;108:1621-1627.
21. Nicolela MT, Martinez-Bello C, Morrison CA, et al. Scanning laser polarimetry in a selected group of patients with glaucoma and normal controls. Am J Ophthalmol. 2001;132:845-854.
22. Sanchez-Galeana C, Bowd C, Blumenthal EZ, et al. Using optical imaging summary data to detect glaucoma. Ophthalmology. 2001;108:1812-1818.
23. Zangwill LM, Bowd C, Berry CC, et al. Discriminating between normal and glaucomatous eyes using the Heidelberg Retina Tomograph, GDx Nerve Fiber Analyzer, and Optical Coherence Tomograph. Arch Ophthalmol. 2001;119:985-993.
24. Greaney MJ, Hoffman DC, Garway-Heath DF, et al. Comparison of optic nerve imaging methods to distinguish normal eyes from those with glaucoma. Invest Ophthalmol Vis Sci. 2002;43:140-145.
25. Kesen MR, Spaeth GL, Henderer JD, et al. The Heidelberg Retina Tomograph vs clinical impression in the diagnosis of glaucoma. Am J Ophthalmol. 2002;133:613-616.
26. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
27. Schuman JS, Pedut-Kloizman T, Hertzmark E, et al. Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography. Ophthalmology. 1996;103:1889-1898.
28. Blumenthal EZ, Williams JM, Weinreb RN, et al. Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. Ophthalmology. 2000;107:2278-2282.
29. Mistlberger A, Liebmann JM, Greenfield DS, et al. Heidelberg retina tomography and optical coherence tomography in normal, ocular-hypertensive, and glaucomatous eyes. Ophthalmology. 1999;106:2027-2032.
30. Pieroth L, Schuman JS, Hertzmark E, et al. Evaluation of focal defects of the nerve fiber layer using optical coherence tomography. Ophthalmology. 1999;106:570-579.
31. Bowd C, Weinreb RN, Williams JM, Zangwill LM. The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. Arch Ophthalmol. 2000;118:22-26.
32. Hoh ST, Greenfield OS, Mistlberger A, et al. Optical coherence tomography and scanning laser polarimetry in normal, ocular hypertensive, and glaucomatous eyes. Am J Ophthalmol. 2000;129:129-135.
33. Zangwill LM, Williams J, Berry CC, et al. A comparison of optical coherence tomography and retinal nerve fiber layer photography for detection of nerve fiber layer damage in glaucoma. Ophthalmology. 2000;107:1309-1315.
34. Guedes V, Schuman JS, Hertzmark E, et al. Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. Ophthalmology. 2003;110:177-189.
35. Kanamori A, Nakamura M, Escano MF, et al. Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography. Am J Ophthalmol. 2003;135:513-520.
36. Advanced Glaucoma Intervention Study. 2: visual field test scoring and reliability. Ophthalmology. 1994;101:1445-1455.
37. Wild JM, Pacey IE, O'Neill EC, Cunlitfe IA. The SITA perimetric threshold algorithms in glaucoma. Invest Ophthalmol Vis Sci. 1999;40:1998-2009.
38. Bengtsson B, Heljl A. Comparing significance and magnitude of glaucomatous visual field defects using the SITA and Full Threshold strategies. Acta Ophthalmol Scand. 1999;77:143-146.
39. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-332.
40. Pedut-Kloizman T, Pakter HM, Schuman JS, et al. Ophthalmic diagnosis using optical coherence tomography. Ophthalmol Clin North Am. 1998;11:1178-1181.
41. Woolson RF, O'Gorman TW. A comparison of several tests for censored paired data. Stat Med. 1992;11:193-208.
42. Vesti E, Johnson CA, Chauhan BC. Comparison of different methods for detecting glaucomatous visual field progression. Invest Ophthalmol Vis Sci. 2003;44:3873-3879.
43. Airaksinen PJ, Drance SM, Douglas GR, Schulzer M. Neuroretinal rim areas and visual field indices in glaucoma. Am J Ophthalmol. 1985;99:107-110.
44. Jonas JB, Grundler AE. Correlation between mean visual field loss and morphometric optic disk variables in the open-angle glaucomas. Am J Ophthalmol. 1997;124:488-497.
45. Bartz-Schmidt KU, Thumann G, Jonescu-Cuypers CP, Krieglstein GK. Quantitative morphologic and functional evaluation of the optic nerve head in chronic open-angle glaucoma. Surv Ophthalmol. 1999;44(suppl 1):S41-S53.
46. Harwerth RS, Carter-Dawson L, Shen F, et al. Ganglion cell losses underlying visual field defects from experimental glaucoma. Invest Ophthalmol Vis Sci. 1999;40:2242-2250.
47. Garway-Heath DF, Holder GE, Fitzke FW, Hitchings RA. Relationship between electrophysiological, psychophysical, and anatomical measurements in glaucoma. Invest Ophthalmol Vis Sci. 2002;43:2213-2220.
48. Paunescu LA, Schuman JS, Price LL, et al. Reproducibility of nerve fiber thickness, macular thickness and optic nerve head measurements using StratusOCT. Invest Ophthalmol Vis Sci. 2004;45:1716-1724.
49. Mikelberg FS, Schulzer M, Drance SM, Lau W. The rate of progression of scotomas in glaucoma. Am J Ophthalmol. 1986;101:1-6.
50. Chauhan BC, Drance SM, Douglas GR. The use of visual field indices in detecting changes in the visual field in glaucoma. Invest Ophthalmol Vis Sci. 1990;31:512-520.
51. Morgan RK, Feuer WJ, Anderson DR. Statpac 2 glaucoma change probability. Arch Ophthalmol. 1991;109:1690-1692.
52. Glaucoma Laser Trial Research Group. The Glaucoma Laser Trial (GLT), 6: treatment group differences in visual field changes. Am J Ophthalmol. 1995;120:10-22.
53. Smith SD, Katz J, Quigley HA. Analysis of progressive change in automated visual fields in glaucoma. Invest Ophthalmol Vis Sci. 1996;37:1419-1428.
54. Katz J, Gilbert D, Quigley HA, Sommer A. Estimating progression of visual field loss in glaucoma. Ophthalmology. 1997;104:1017-1025.
55. Rasker MT, van den Enden A, Bakker D, Hoyng PF. Rate of visual field loss in progressive glaucoma. Arch Ophthalmol. 2000;118:481-488.
56. Spry PG, Johnson CA. Identification of progressive glaucomatous visual field loss. Surv Ophthalmol. 2002;47:158-173.